Reuters logo
BRIEF - Moody's comments on Bristol-Myers Squibb
July 2, 2012 / 3:48 PM / 5 years ago

BRIEF - Moody's comments on Bristol-Myers Squibb

July 2 (Reuters) - Moody’s says Bristol-Myers Squibb’s acquisition of Amylin is credit positive, A2 rating affirmed

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below